# Gland Pharma Limited – FDA Inspection, Feb 25, 2025

Source: https://www.keypedia.com/records/fda_inspections/gland-pharma-limited/2972bd2d-c5e8-4a15-963c-a84d5805c9d3
Source feed: FDA_Inspections

> FDA inspection 1261860 of Gland Pharma Limited, February 25, 2025. Classification: Voluntary Action Indicated (VAI). 3 citations under 21 CFR part 211. Form 483 issued. 4 other FDA inspections on record for this company.

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1261860
- Company Name: Gland Pharma Limited
- Inspection Date: 2025-02-25
- Classification: Voluntary Action Indicated (VAI)
- Classification Code: VAI
- Project Area: Generic Drug Evaluation
- Product Type: Human Drugs
- Center: Human Drugs
- Office Name: Office of Inspections and Investigations
- Citation Count: 3

## Related Documents

- FDA Inspection 1245692 - 2024-05-24
- [FDA Inspection 1199204 - 2023-01-27](https://www.keypedia.com/records/fda_inspections/gland-pharma-limited/3204a6bf-ba56-427c-bce5-3387799260ad)
- [FDA Inspection 1052383 - 2018-04-20](https://www.keypedia.com/records/fda_inspections/gland-pharma-limited/bcfef7a6-3c1d-45b7-aa02-c938c6c50db1)
- FDA Inspection 951916 - 2015-10-29

## Related Officers

- [Ashar P. Parikh](https://www.keypedia.com/people/ashar-p-parikh/f5430c51-31c7-44bb-90f7-1ec8ae581343)

Company: https://www.keypedia.com/companies/gland-pharma-limited/2bdef9e1-be40-4167-95c8-f08cba22365c

Office: https://www.keypedia.com/offices/office-of-inspections-and-investigations/7dd0b904-a3df-46bc-a7b2-70ddb6f809c8
